调强放疗同步替吉奥结合胆汁引流术治疗不能手术胆管癌的疗效分析  

Clinical analysis of unresectable cholangiocarcinoma treated with IMRT and S-1 after biliary drainage

作　　者：王武龙[1,2] 王春雷[3] 孟宪梅[4] 潘小平[2] 于柏清 尤奎雨 王鑫[2] 田继刚 张银梅[2] 冯建国[2] 宋丽君[2] 边增祥 赵驭骁 高文斌[5] 

机构地区：[1]大连大学研究生学院,116622 [2]包头医学院第二附属医院,014030 [3]包头市第四医院,014030 [4]内蒙古自治区消化病研究所,014030 [5]大连大学附属中山医院,116001

出　　处：《世界最新医学信息文摘》2015年第8期9-11,共3页World Latest Medicine Information Electronic Version

摘　　要：目的探讨常规分割调强放疗同步替吉奥结合胆汁引流术治疗不能手术胆管癌的疗效。方法选择2011年9月至2013年6月期间住院治疗的不能手术的胆管癌患者的临床资料。根据治疗模式不同,分为同步组和对照组。结果同步组较对照组的副反应略高,但无统计学差异(P>0.05);同步组和对照组的1年生存率分别为53.8%和27.6%,有统计学差异(P=0.01)。结论调强放疗同步替吉奥结合胆汁引流术治疗不能手术胆管癌疗效肯定。ABSTRACT:Objective:To study clinical analysis of unresectable cholangiocarcinoma treated with IMRT and S-1 after biliary drainage. Methods:clinical data unresectable cholangiocarcinoma from 2011 to 2013. according to the different treatment mo-dalities, we divided all of cases into synchronous chemotherapy group and control group. Results:the difference of side effects between two groups had no signiifcant difference (P>0.05);1 year survival rate of synchronous chemotherapy group and control group were 53.8%and 27.6%, there was statistically signiifcant difference (P=0.01). Conclusion:effectiveness of unresectable cholangiocarcinoma treated with IMRT and S-1 after biliary drainage is deifnite.

关 键 词：调强放疗 替吉奥 胆管癌 

分 类 号：R735.8[医药卫生—肿瘤]